☆ 4.6 Review

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review

MICROORGANISMS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Critical Care Medicine

Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study

Jia-Yih Feng et al.

Summary: This retrospective study aimed to investigate the effect of substitutive nebulized colistin on nosocomial pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients. The results showed that substitutive nebulized colistin was associated with better clinical outcomes compared to intravenous colistin.

ANNALS OF INTENSIVE CARE (2023)

添加到收藏夹

Article Infectious Diseases

Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features

Gennaro De Pascale et al.

Summary: This study investigated the clinical use of high-dose aerosolized colistin for COS-AB VAP patients in the ICU. The results showed that this strategy was safe and effective, but its specific role and efficacy in this setting still need further investigation.

ANTIBIOTICS-BASEL (2023)

添加到收藏夹

Review Infectious Diseases

Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review

Jitka Rychlickova et al.

Summary: The emerging resistance of Gram-negative bacteria is a global problem that has led to the reintroduction of colistin as a therapeutic option. However, there are still many questions regarding the safety and efficacy of colistin. This review summarizes the available literature on the use of colistin in critically ill patients, focusing on stability, pharmacokinetics, plasma concentration determination methods, and therapeutic drug monitoring benefits and limitations. Based on these findings, the gaps in knowledge are identified, and future research directions are suggested.

ANTIBIOTICS-BASEL (2023)

添加到收藏夹

Editorial Material Critical Care Medicine

Is Ventilator-Associated Pneumonia More Frequent in Patients With Coronavirus Disease 2019?

Andre C. Kalil et al.

CRITICAL CARE MEDICINE (2022)

添加到收藏夹

Review Critical Care Medicine

Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients

Jacopo Fumagalli et al.

Summary: This review summarized the available evidence regarding the incidence, risk factors, and clinical characteristics of ventilator-associated pneumonia (VAP) in patients undergoing mechanical ventilation due to acute respiratory distress syndrome secondary to SARS-CoV-2 infection (C-ARDS). The majority of VAP cases were caused by Gram-negative bacteria, with occasional cases attributed to herpes virus reactivations and pulmonary aspergillosis. Potential factors driving high VAP incidence rates included immunoparalysis, prolonged ventilation, exposure to immunosuppressants, understaffing, lapses in prevention processes, and overdiagnosis.

CURRENT OPINION IN CRITICAL CARE (2022)

添加到收藏夹

Article Critical Care Medicine

Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19

Charles-Herve Vacheron et al.

Summary: This study estimated the mortality rate of VAP in COVID-19 patients, finding that COVID-19 patients had higher attributable mortality related to VAP, with more than 9% of overall mortality attributed to VAP.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

添加到收藏夹

Article Infectious Diseases

Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia

Aikaterini Gkoufa et al.

Summary: This study assessed the pharmacokinetics of nebulised colistin methanesulfonate (CMS) for the treatment of ventilator-associated pneumonia (VAP) and found that nebulised CMS can achieve high concentrations of formed colistin in the epithelial lining fluid (ELF) while maintaining lower concentrations in plasma.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

添加到收藏夹

Article Medicine, General & Internal

Antibiotic Treatment of Acinetobacter baumannii Superinfection in Patients With SARS-CoV-2 Infection Admitted to Intensive Care Unit: An Observational Retrospective Study

Erika Casarotta et al.

Summary: This study describes the evolution of superinfection with PDR Acinetobacter baumannii in COVID-19 patients on mechanical ventilation and compares the impact of two different antibiotic strategies on microbiological negativization. The results show that the combination therapy of antibiotics leads to microbiological negativization in all patients.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience

Giorgia Montrucchio et al.

Summary: This study investigated the characteristics of COVID-19 ICU patients developing CR-Ab colonization/infection and evaluated mortality risk factors. The results showed a 19% positivity rate for CR-Ab in ICU patients and a 64.7% ICU mortality rate. Deceased patients had higher disease severity scores, and risk factors for invasive infections included extracorporeal membrane oxygenation, septic shock, and elderly age. Additionally, being colonized by CR-Ab was significantly associated with a higher risk of developing invasive infections, while colonized patients without infection had a higher survival rate.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Position of different nebulizer types for aerosol delivery in an adult model of mechanical ventilation

Haijia Hou et al.

Summary: This study investigated the effect of different types and positions of nebulizers on aerosol delivery efficiency during adult mechanical ventilation. The results showed that the type and position of the nebulizer had an impact on aerosol delivery efficiency, but there were no significant differences between different ventilators.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Infectious Diseases

Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections

Anna Kyriakoudi et al.

Summary: This study compared the pharmacokinetics of inhaled colistin administered through vibrating mesh nebulizers (VMNs) and generic jet nebulizers (JNs) in VARI patients. The results showed comparable colistin exposures in the epithelial lining fluid (ELF) between VMN and JN, suggesting that JN may be a viable alternative to VMN. However, therapeutic drug monitoring in the ELF is advised due to low exposure, high variability, and appreciable systemic absorption.

ANTIBIOTICS-BASEL (2022)

添加到收藏夹

Review Infectious Diseases

Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?

Adrian J. Brink et al.

Summary: Bacterial infections have a significant impact on hospital outcomes during the COVID-19 pandemic. The pandemic has led to an increase in hospital-onset infections and antibiotic resistance, particularly among Gram-negative bacteria such as carbapenemase-producing Klebsiella pneumoniae, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.

CURRENT OPINION IN INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Critical Care Medicine

Carbapenem Antibiotics for the Empiric Treatment of Nosocomial Pneumonia A Systematic Review and Meta-analysis

Mackenzie Howatt et al.

Summary: Carbapenem-based empiric regimens showed lower mortality rates compared with non-carbapenems, but had a trend toward developing resistance. The mortality benefit was more prominent in trials with lower disease severity and was not associated with the presence of Pseudomonas.

CHEST (2021)

添加到收藏夹

Review Critical Care Medicine

Effectiveness and safety of adjunctive inhaled antibiotics for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials

Rui Tang et al.

Summary: Adjunctive inhaled antibiotic therapy can improve clinical cure rates and microbiological eradication in VAP patients, but does not reduce mortality. There is no increased risk of renal impairment with adjunctive inhaled antibiotics, but an increased risk of bronchospasm may be present.

JOURNAL OF CRITICAL CARE (2021)

添加到收藏夹

Review Infectious Diseases

Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials

Antoine Monsel et al.

Summary: This review examines methodological requirements for future RCTs on nebulized antibiotics in VAP, emphasizing dose requirements, nebulizer types, lung concentrations, and ventilator settings. Future RCTs should compare nebulized antibiotics to intravenous administration, with specific inclusion criteria for patient selection and drug dosing.

CURRENT OPINION IN INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Rescuing the Last-Line Polymyxins: Achievements and Challenges

Sue C. Nang et al.

Summary: Antibiotic resistance is a major global health challenge, and polymyxins have been revived as a last-line therapeutic option for infections caused by multidrug-resistant Gram negative bacteria. Recent efforts have been made to elucidate the properties of polymyxins and develop scientifically based dosage regimens to ensure safe and effective use. Challenges remain in optimizing clinical use and discovering new-generation polymyxins to overcome toxicities and narrow therapeutic windows.

PHARMACOLOGICAL REVIEWS (2021)

添加到收藏夹

Article Critical Care Medicine

Hospital-Acquired Infections in Critically Ill Patients With COVID-19

Giacomo Grasselli et al.

Summary: Critically ill patients with COVID-19 are at high risk for hospital-acquired infections (HAIs), especially ventilator-associated pneumonia (VAP) and bloodstream infections (BSIs) caused by multidrug-resistant organisms. HAIs prolong mechanical ventilation and hospitalization, and those complicated by septic shock nearly double mortality rate.

CHEST (2021)

添加到收藏夹

Article

Comparative evaluation of ventilator-associated pneumonia in critically ill COVID- 19 and patients infected with other corona viruses: a systematic review and meta-analysis

Shikha Jain et al.

Monaldi Archives for Chest Disease (2021)

添加到收藏夹

Review Oncology

Aerosol delivery via invasive ventilation: a narrative review

Hui-Ling Lin et al.

Summary: Mechanically ventilated patients face challenges in receiving medical aerosols, but the introduction of new aerosol technology can optimize aerosol delivery. Despite gaps and challenges, clinical practice can improve drug delivery consistency and provide safer and more effective care through these techniques.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018

Pattarachai Kiratisin et al.

Summary: In Africa/Middle East and Latin America, carbapenemase-producing Enterobacterales without MBL were not resistant to CZA; resistance rates were <= 4.5% in Europe and Asia/South Pacific. Enterobacterales in Latin America predominantly carried KPC carbapenemase, while in Africa/Middle East OXA-48-like carbapenemases were most frequently detected, and in Asia/South Pacific most isolates carried NDM carbapenemases.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)

添加到收藏夹

Review Microbiology

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Yinggang Zhu et al.

Summary: Clinical evidence supports the benefits of nebulized colistimethate sodium (CMS) for treating lower respiratory tract infections caused by multidrug-resistant Gram-negative bacteria. However, the slower conversion of CMS to colistin compared to renal clearance may result in low plasma and lung colistin concentrations with intravenous administration, increasing the risk of treatment failure. Future research should focus on assessing the pharmacokinetics/pharmacodynamics of high-dose colistin nebulization, as well as comparing nebulized CMS to intravenous antibiotics in patients with ventilator-associated pneumonia caused by drug-resistant bacteria.

MICROORGANISMS (2021)

添加到收藏夹

Editorial Material Critical Care Medicine

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin

J. J. Rouby et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Letter Medicine, General & Internal

Clinical Characteristics of Covid-19 in New York City

Parag Goyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Immunology

Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)

Mohamed Abd El-Gawad El-Sayed Ahmed et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji et al.

PHARMACOTHERAPY (2019)

添加到收藏夹

Review Public, Environmental & Occupational Health

The Old and the New Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How

Ilias Karaiskos et al.

FRONTIERS IN PUBLIC HEALTH (2019)

添加到收藏夹

Article Infectious Diseases

Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia

Adela Benitez-Cano et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Size Distribution of Colistin Delivery by Different Type Nebulizers and Concentrations During Mechanical Ventilation

Ching-Yi Liu et al.

PHARMACEUTICS (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular Mechanisms of Neurotoxicity Induced by Polymyxins and Chemoprevention

Chongshan Dai et al.

ACS CHEMICAL NEUROSCIENCE (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens

Ilias Karaiskos et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)

添加到收藏夹

Article Respiratory System

Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria

Junsu Choe et al.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)

添加到收藏夹

Article Urology & Nephrology

Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury

Todd A. Miano et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

添加到收藏夹

Review Infectious Diseases

Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis

Konstantinos Z. Vardakas et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)

添加到收藏夹

Article Infectious Diseases

Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria

Kevin Bihan et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

添加到收藏夹

Review Infectious Diseases

Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis

Konstantinos Z. Vardakas et al.

JOURNAL OF INFECTION (2018)

添加到收藏夹

Article Respiratory System

Aerosol Therapy for Pneumonia in the Intensive Care Unit

Charles-Edouard Luyt et al.

CLINICS IN CHEST MEDICINE (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Colistin: still a lifesaver for the 21st century?

Ilias Karaiskos et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)

添加到收藏夹

Review Infectious Diseases

Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges

G. Poulakou et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)

添加到收藏夹

Article Critical Care Medicine

Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii

Ji Young Jang et al.

JOURNAL OF CRITICAL CARE (2017)

添加到收藏夹

Article Respiratory System

Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii

Yong Kyun Kim et al.

JOURNAL OF THORACIC DISEASE (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical Pharmacokinetics and Pharmacodynamics of Colistin

Nicolas Gregoire et al.

CLINICAL PHARMACOKINETICS (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects

Garyphallia Poulakou et al.

DRUGS (2017)

添加到收藏夹

Article Infectious Diseases

Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases

J. Rello et al.

CLINICAL MICROBIOLOGY AND INFECTION (2017)

添加到收藏夹

Article Infectious Diseases

Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients

J. Rello et al.

CLINICAL MICROBIOLOGY AND INFECTION (2017)

添加到收藏夹

Article Immunology

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Andre C. Kalil et al.

CLINICAL INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Infectious Diseases

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate

Juan P. Horcajada et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)

添加到收藏夹

Article Infectious Diseases

Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?

Thien B. Tran et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)

添加到收藏夹

Article Critical Care Medicine

Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial

Sami Abdellatif et al.

ANNALS OF INTENSIVE CARE (2016)

添加到收藏夹

Article Critical Care Medicine

The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia: A Systematic Review and Metaanalysis

Antonis Valachis et al.

CRITICAL CARE MEDICINE (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

A review on colistin nephrotoxicity

Atefeh Ordooei Javan et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)

添加到收藏夹

Review Infectious Diseases

Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis

Dong Liu et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)

添加到收藏夹

Article Microbiology

Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients

Matthieu Boisson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

添加到收藏夹

Article Infectious Diseases

Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: A systematic review and meta-analysis

Wan-Jie Gua et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)

添加到收藏夹

Review Anesthesiology

Aerosolized Antibiotics for Ventilator-associated Pneumonia Lessons from Experimental Studies

Jean-Jacques Rouby et al.

ANESTHESIOLOGY (2012)

添加到收藏夹

Article Anesthesiology

Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii

Qin Lu et al.

ANESTHESIOLOGY (2012)

添加到收藏夹

Article Critical Care Medicine

Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients

Zoe E. Athanassa et al.

INTENSIVE CARE MEDICINE (2012)

添加到收藏夹

Letter Infectious Diseases

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii

Marie Kempf et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)

添加到收藏夹

Article Microbiology

Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

Phillip J. Bergen et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

添加到收藏夹

Article Critical Care Medicine

Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration

Roberto Imberti et al.

CHEST (2010)

添加到收藏夹

Article Critical Care Medicine

Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa

Qin Lu et al.

INTENSIVE CARE MEDICINE (2010)

添加到收藏夹

Article Critical Care Medicine

Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study

Dimitrios K. Matthaiou et al.

CRITICAL CARE MEDICINE (2008)

添加到收藏夹

Review Infectious Diseases

Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis

Eleni Ioannidou et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)

添加到收藏夹

Letter Medicine, General & Internal

Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome

Karen S. McCoy

NEW ENGLAND JOURNAL OF MEDICINE (2007)

添加到收藏夹

Article Critical Care Medicine

Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa

Spyros D. Mentzelopoulos et al.

INTENSIVE CARE MEDICINE (2007)

添加到收藏夹

Article Critical Care Medicine

Bronchial constriction and inhaled colistin in cystic fibrosis

GA Alothman et al.

CHEST (2005)

添加到收藏夹

Article Microbiology

Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration

J Li et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)

添加到收藏夹

Article Microbiology

Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography

J Li et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.